Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ)
CNY 54.99
(1.1%)
CNY 54.99
(1.1%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.56 Billion CNY | 8.36% |
| 2022 | 1.44 Billion CNY | 11.94% |
| 2021 | 1.29 Billion CNY | 24.44% |
| 2020 | 1.03 Billion CNY | 87.26% |
| 2019 | 554.63 Million CNY | -0.86% |
| 2018 | 559.46 Million CNY | 113.59% |
| 2017 | 261.93 Million CNY | 181.9% |
| 2016 | 92.91 Million CNY | 30.74% |
| 2015 | 71.06 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 319.29 Million CNY | -25.03% |
| 2024 Q1 | 309.93 Million CNY | -46.88% |
| 2024 Q2 | 425.89 Million CNY | 37.41% |
| 2023 Q4 | 583.47 Million CNY | 64.08% |
| 2023 FY | 1.56 Billion CNY | 8.36% |
| 2023 Q1 | 278.11 Million CNY | -29.08% |
| 2023 Q2 | 356.32 Million CNY | 28.12% |
| 2023 Q3 | 355.61 Million CNY | -0.2% |
| 2022 Q4 | 392.17 Million CNY | -0.66% |
| 2022 FY | 1.44 Billion CNY | 11.94% |
| 2022 Q2 | 393.03 Million CNY | 47.35% |
| 2022 Q1 | 266.73 Million CNY | -47.05% |
| 2022 Q3 | 394.77 Million CNY | 0.44% |
| 2021 Q1 | 237.14 Million CNY | 11.03% |
| 2021 Q4 | 503.79 Million CNY | 120.72% |
| 2021 FY | 1.29 Billion CNY | 24.44% |
| 2021 Q3 | 228.24 Million CNY | -29.39% |
| 2021 Q2 | 323.25 Million CNY | 36.31% |
| 2020 Q1 | 157.09 Million CNY | -39.66% |
| 2020 FY | 1.03 Billion CNY | 87.26% |
| 2020 Q2 | 297.81 Million CNY | 89.57% |
| 2020 Q3 | 370.12 Million CNY | 24.28% |
| 2020 Q4 | 213.6 Million CNY | -42.29% |
| 2019 Q3 | 23.42 Million CNY | -83.31% |
| 2019 FY | 554.63 Million CNY | -0.86% |
| 2019 Q4 | 260.36 Million CNY | 1011.34% |
| 2019 Q2 | 140.33 Million CNY | 7.53% |
| 2019 Q1 | 130.5 Million CNY | 0.1% |
| 2018 Q4 | 130.36 Million CNY | 0.0% |
| 2018 FY | 559.46 Million CNY | 113.59% |
| 2017 FY | 261.93 Million CNY | 181.9% |
| 2016 FY | 92.91 Million CNY | 30.74% |
| 2015 FY | 71.06 Million CNY | 0.0% |